With goal of improving patients’ overall care, Pittsburgh-based pharmacy is aiming to be licensed in all 50 states.
Pittsburgh is now home to a new specialty pharmacy: Zeal. The pharmacy was initially licensed in March of this year, and can now dispense to patients nationwide, with the receipt of non-resident licensure. The pharmacy is currently licensed to operate in 45 states, with the remainder in process and expected by Q4.
Zeal is also in-process and scheduled for survey for accreditation through both URAC and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy and rare disease designations.
That technology features web-based patient management platforms that allows the Zeal team to customize the patient journey for each patient, based on their clinical presentation and needs. Patients may elect multiple modes of communication with their clinical team, including text and email, and can leverage smart device technology in their homes to enhance the overall care needed to manage their specialty diagnosis.
" … It is our goal to manage multiple rare disease medications through our first-in-class care model, building our own ‘zeal’ of support for these traditionally underrepresented patients,” says Brenden Harper, CFO and co-founder.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.